PETS: PetMed Express, Inc. - Summary | Jitta

PetMed Express, Inc.

NASDAQ:PETS

Price
$14.96
Loss Chance
49.6%
4.13JITTA SCORE
314.51%Over Jitta Line
Jitta Ranking
4,137 / 5,159
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (26)
Recent Business Performance (26)
Financial Strength (71)
Return to Shareholders (56)
Competitive Advantage (45)
Jitta Signs
Debt LevelLow Long Term Debt
Cash Conversion CycleLess than 30 days
Revenue and EarningRevenue decline from 2020-2023
Operating MarginDeclined
Recent Business PerformanceEarning decline 158.28% in the last quarter (yoy)
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
4.13
314.51%
Other Specialty Retail
4.70
64.89%
5.35
705.21%
5.35
705.21%
COMPANY DESCRIPTION
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.